Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Desguerre

Showing results (111-120 of 235) with videos related to

Pageof 24
Sort By:
Journal of Clinical Pharmacology|November 10, 2018
Simulations of Valproate Doses Based on an External Evaluation of Pediatric Population Pharmacokinetic ModelsManon Tauzin, Jean-Marc Tréluyer, Rima Nabbout, et al.
Medecine Sciences : M/S|November 18, 2024
[Benefit of treatment with rituximab in autoimmune myasthenia gravis in children]Agathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Pediatric Pulmonology|October 29, 2020
Assessment of respiratory muscles and motor function in children with SMA treated by nusinersenMarta Gómez-García de la Banda, Alessandro Amaddeo, Sonia Khirani, et al.
Rheumatology (Oxford, England)|October 2, 2015
Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositisCyril Gitiaux, Marie De Antonio, Jessie Aouizerate, et al.
European Journal of Neurology|May 2, 2024
Ceroid lipofuscinosis type 2 disease: Effective presymptomatic therapy-Oldest case of a presymptomatic enzyme therapyDelphine Breuillard, Lisa Ouss, Marie Thérèse Le Normand, et al.
European Journal of Medical Genetics|July 19, 2015
Rare ACTG1 variants in fetal microlissencephalyKarine Poirier, Jelena Martinovic, Annie Laquerrière, et al.
Pediatric Neurology|October 13, 2022
Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective StudyAi Tien Nguyen, Camille Cotteret, Chloé Durrleman, et al.
Journal of Clinical Pharmacology|November 27, 2020
Dosing Recommendations for Lamotrigine in Children: Evaluation Based on Previous and New Population Pharmacokinetic ModelsManon Tauzin, Jean-Marc Tréluyer, Rima Nabbout, et al.
Neurology|March 22, 2022
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French ExperienceAgathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Translational Psychiatry|February 19, 2020
Behavior and interaction imaging at 9 months of age predict autism/intellectual disability in high-risk infants with West syndromeLisa Ouss, Giuseppe Palestra, Catherine Saint-Georges, et al.
Pageof 24

Showing results (111-120 of 235) with videos related to

Sort By:
Pageof 24
Journal of Clinical Pharmacology|November 10, 2018
Simulations of Valproate Doses Based on an External Evaluation of Pediatric Population Pharmacokinetic ModelsManon Tauzin, Jean-Marc Tréluyer, Rima Nabbout, et al.
Medecine Sciences : M/S|November 18, 2024
[Benefit of treatment with rituximab in autoimmune myasthenia gravis in children]Agathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Pediatric Pulmonology|October 29, 2020
Assessment of respiratory muscles and motor function in children with SMA treated by nusinersenMarta Gómez-García de la Banda, Alessandro Amaddeo, Sonia Khirani, et al.
Rheumatology (Oxford, England)|October 2, 2015
Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositisCyril Gitiaux, Marie De Antonio, Jessie Aouizerate, et al.
European Journal of Neurology|May 2, 2024
Ceroid lipofuscinosis type 2 disease: Effective presymptomatic therapy-Oldest case of a presymptomatic enzyme therapyDelphine Breuillard, Lisa Ouss, Marie Thérèse Le Normand, et al.
European Journal of Medical Genetics|July 19, 2015
Rare ACTG1 variants in fetal microlissencephalyKarine Poirier, Jelena Martinovic, Annie Laquerrière, et al.
Pediatric Neurology|October 13, 2022
Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective StudyAi Tien Nguyen, Camille Cotteret, Chloé Durrleman, et al.
Journal of Clinical Pharmacology|November 27, 2020
Dosing Recommendations for Lamotrigine in Children: Evaluation Based on Previous and New Population Pharmacokinetic ModelsManon Tauzin, Jean-Marc Tréluyer, Rima Nabbout, et al.
Neurology|March 22, 2022
Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis: The French ExperienceAgathe Molimard, Cyril Gitiaux, Christine Barnerias, et al.
Translational Psychiatry|February 19, 2020
Behavior and interaction imaging at 9 months of age predict autism/intellectual disability in high-risk infants with West syndromeLisa Ouss, Giuseppe Palestra, Catherine Saint-Georges, et al.
Pageof 24